{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:23:15Z","timestamp":1794345795379,"version":"4.9.0"},"reference-count":32,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Linear IgA disease (LAD) is a rare autoimmune blistering disease with linear IgA deposits along the basement membrane zone. Direct immunofluorescence remains the gold standard for diagnosis, but other diagnostic measures reported in recent literature have proven useful in the setting of inconclusive preliminary results. Dapsone is a commonly used treatment, but many therapeutic agents have emerged in recent years. The objective of this study is to provide a comprehensive overview of updates on the diagnosis and management of LAD. Materials and Methods: A literature search was conducted from May to June of 2021 for articles published in the last 5 years that were related to the diagnosis and management of LAD. Results: False-negative results in cases of drug-induced LAD and the presence of IgG and IgM antibodies on immunofluorescence studies were reported. Serration pattern analysis has been reported to be useful in distinguishing LAD from sublamina densa-type LAD. Rituximab, omalizumab, etanercept, IVIg, sulfonamides, topical corticosteroids, and others have been used successfully in adult and pediatric patients with varying disease severity. Topical corticosteroids were preferred for pediatric patients while rituximab and IVIg were used in adults with recalcitrant LAD. Sulfonamides were utilized in places without access to dapsone. Conclusion: In cases where preliminary biopsy results are negative and clinical suspicion is high, repeat biopsy and additional diagnostic studies should be used. Patient factors such as age, medical comorbidities, and disease severity play a role in therapeutic selection.<\/jats:p>","DOI":"10.3390\/medicina57080818","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T10:54:41Z","timestamp":1628765681000},"page":"818","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Updates in the Diagnosis and Management of Linear IgA Disease: A Systematic Review"],"prefix":"10.3390","volume":"57","author":[{"given":"Leah","family":"Shin","sequence":"first","affiliation":[{"name":"Loma Linda University School of Medicine, Loma Linda, CA 92708, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Jeffrey T.","family":"Gardner","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Loma Linda University School of Medicine, Loma Linda, CA 92708, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Harry","family":"Dao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Loma Linda University School of Medicine, Loma Linda, CA 92708, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,12]]},"reference":[{"key":"ref_1","unstructured":"Bernett, C.N., Fong, M., Rosario-Collazo, J.A., and Linear, I.G.A. (2021, June 29). Dermatosis. [Updated 2021 Jan 15], StatPearls [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK526113\/."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Hashimoto, T., Yamagami, J., and Zone, J.J. (2021). History, Diagnosis, Pathogenesis, and Nomenclature in Sublamina Dense-Type Linear IgA Disease. JAMA Dermatol.","DOI":"10.1001\/jamadermatol.2021.0761"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/cup.12742","article-title":"False-negative direct immunofluorescence testing in vancomycin-induced linear IgA bullous dermatosis: A diagnostic pitfall","volume":"43","author":"Winn","year":"2016","journal-title":"J. Cutan. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jid.2017.12.035","article-title":"Vancomycin Mediates IgA Autoreactivity in Drug-Induced Linear IgA Bullous Dermatosis","volume":"138","author":"Yamagami","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1590\/abd1806-4841.2019940208","article-title":"Consensus on the treatment of autoimmune bullous dermatoses: Dermatitis herpetiformis and linear IgA bullous dermatosis\u2014Brazilian Society of Dermatology","volume":"94","author":"Vale","year":"2019","journal-title":"An. Bras. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e13210","DOI":"10.1111\/dth.13210","article-title":"Successful treatment of a case of idiopathic linear IgA bullous dermatosis with oral sulfasalazine","volume":"33","author":"Yang","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/ced.12892","article-title":"Childhood linear IgA bullous dermatosis successfully treated with oral nicotinamide","volume":"41","author":"Cui","year":"2016","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jdcr.2018.11.004","article-title":"Linear IgA bullous dermatosis treated with rituximab","volume":"5","author":"Pinard","year":"2019","journal-title":"JAAD Case Rep."},{"key":"ref_9","first-page":"e12911","article-title":"A case of recalcitrant linear IgA bullous dermatosis: Successfully treated with rituximab","volume":"32","year":"2019","journal-title":"Dermatol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fimmu.2018.00248","article-title":"Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases","volume":"9","author":"Lamberts","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jdcr.2020.12.029","article-title":"Immunologic overlap in a case of linear IgG\/IgA bullous dermatosis responsive to rituximab","volume":"9","author":"Nedosekin","year":"2021","journal-title":"JAAD Case Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1097\/ICO.0000000000001024","article-title":"Combined Use of Rituximab and Intravenous Immunoglobulin for Severe Autoimmune Cicatricial Conjunctivitis\u2014An Interventional Case Series","volume":"35","author":"Steger","year":"2016","journal-title":"Cornea"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jdcr.2019.08.019","article-title":"Linear IgA bullous dermatosis successfully treated with omalizumab: A case report","volume":"5","author":"Maalouf","year":"2019","journal-title":"JAAD Case Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4103\/ijd.IJD_55_20","article-title":"A case of linear IgA bullous dermatosis successfully treated with omalizumab","volume":"65","author":"Patel","year":"2020","journal-title":"Indian J. Dermatol."},{"key":"ref_15","first-page":"14","article-title":"Linear IgA bullous dermatosis associated with ulcerative proctitis: Treatment challenge","volume":"24","author":"Yetto","year":"2018","journal-title":"Derm. Online J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jpeds.2018.07.070","article-title":"Chronic Bullous Dermatosis of Childhood and the String of Pearls Sign","volume":"202","author":"Tate","year":"2018","journal-title":"J. Pediatr."},{"key":"ref_17","first-page":"786","article-title":"Linear immunoglobulin A dermatosis mimicking toxic epidermal necrolysis: A case report of etanercept treatment","volume":"178","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_18","first-page":"195","article-title":"Spectrum of Autoimmune Bullous Diseases in Northern Greece. A 4-year Retrospective Study and Review of the Literature","volume":"25","author":"Patsatsi","year":"2017","journal-title":"Acta Dermatovenerol. Croat."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"adv00298","DOI":"10.2340\/00015555-3662","article-title":"Intravenous Immunoglobulins in a Series of 32 Rare and Recalcitrant Immune Dermatoses","volume":"100","author":"Scarpone","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"ref_20","first-page":"e440","article-title":"Corticoides t\u00f3picos como alternativa terap\u00e9utica en la dermatosis ampollosa por inmunoglobulina A lineal de la infancia. Caso cl\u00ednico","volume":"114","author":"Galar","year":"2016","journal-title":"Arch. Argent. Pediatr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/1203475418760458","article-title":"Uncomplicated Neonatal Linear IgA Bullous Dermatosis: A Case Report","volume":"22","author":"Mazurek","year":"2018","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5070\/D32311037271","article-title":"Flame figures in linear IgA bullous dermatosis: A novel histopathologic finding","volume":"23","author":"Fulton","year":"2017","journal-title":"Dermatol. Online J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1111\/ijd.14253","article-title":"Linear IgA bullous dermatosis presenting as chronic prurigo: Unveiling of the diagnosis by serrated pattern analysis","volume":"57","author":"Shetty","year":"2018","journal-title":"Int. J. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Becker, M., Schumacher, N., Schmidt, E., Zillikens, D., and Sadik, C.D. (2021). Evaluation and Comparison of Clinical and Laboratory Characterstics of Patients With IgA Epidermolysis Bullosa Acquisita, Linear IgA Bullous Dermatosis, and IgG Epidermolysis Bullosa Acquisita. JAMA Dermatol.","DOI":"10.1001\/jamadermatol.2021.0762"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1590\/abd1806-4841.20164630","article-title":"Linear IgA and IgG bullous dermatosis","volume":"91","author":"Fernandes","year":"2016","journal-title":"An. Bras. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1111\/ajd.13558","article-title":"Rare case of linear IgA bullous dermatosis showing IgA, IgG and IgM reactivity","volume":"62","author":"Lim","year":"2021","journal-title":"Australas. J. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/bjd.15232","article-title":"A clinical and serological study of linear IgA bullous dermatosis without linear immunoglobulin deposition other than IgA at the basement membrane zone using direct immunofluorescence","volume":"177","author":"Ohata","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/pde.14368","article-title":"Spectrum of autoimmune bullous diseases among children in Kuwait","volume":"38","author":"Nanda","year":"2020","journal-title":"Pediatr. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1590\/abd1806-4841.20187304","article-title":"Adult linear IgA bullous dermatosis: Report of three cases","volume":"93","author":"Machado","year":"2018","journal-title":"An. Bras. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"bcr2016218315","DOI":"10.1136\/bcr-2016-218315","article-title":"Suspected case of chronic bullous disease of childhood in a rural area of Southern Mozambique","volume":"2017","author":"Varo","year":"2017","journal-title":"BMJ Case Rep."},{"key":"ref_31","first-page":"e86","article-title":"Neonatal and self-healing linear immunoglobulin A dermatosis","volume":"34","author":"Giraud","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Egami, S., Suzuki, C., Kurihara, Y., Yamagami, J., Kubo, A., Funakoshi, T., Nishie, W., Matsumura, K., Matsushima, T., and Kawaida, M. (2021). Neonatal Linear IgA Bullous Dermatosis Mediated by Breast Milk\u2013Borne Maternal IgA. JAMA Dermatol.","DOI":"10.1001\/jamadermatol.2021.2392"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/8\/818\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:44:44Z","timestamp":1760165084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/8\/818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,12]]},"references-count":32,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["medicina57080818"],"URL":"https:\/\/doi.org\/10.3390\/medicina57080818","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,12]]}}}